Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Water, sanitation, and hygiene interventions to reduce diarrhoea in less developed countries: a systematic review and meta-analysis.

Fewtrell L, Kaufmann RB, Kay D, Enanoria W, Haller L, Colford JM Jr.

Lancet Infect Dis. 2005 Jan;5(1):42-52. Review.

PMID:
15620560
2.

Cryptosporidium parvum IMP dehydrogenase: identification of functional, structural, and dynamic properties that can be exploited for drug design.

Umejiego NN, Li C, Riera T, Hedstrom L, Striepen B.

J Biol Chem. 2004 Sep 24;279(39):40320-7. Epub 2004 Jul 21.

3.

Complete genome sequence of the apicomplexan, Cryptosporidium parvum.

Abrahamsen MS, Templeton TJ, Enomoto S, Abrahante JE, Zhu G, Lancto CA, Deng M, Liu C, Widmer G, Tzipori S, Buck GA, Xu P, Bankier AT, Dear PH, Konfortov BA, Spriggs HF, Iyer L, Anantharaman V, Aravind L, Kapur V.

Science. 2004 Apr 16;304(5669):441-5. Epub 2004 Mar 25.

4.

Gene transfer in the evolution of parasite nucleotide biosynthesis.

Striepen B, Pruijssers AJ, Huang J, Li C, Gubbels MJ, Umejiego NN, Hedstrom L, Kissinger JC.

Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3154-9. Epub 2004 Feb 18.

5.

Azithromycin as treatment for cryptosporidiosis in human immunodeficiency virus disease.

Kadappu KK, Nagaraja MV, Rao PV, Shastry BA.

J Postgrad Med. 2002 Jul-Sep;48(3):179-81.

6.

Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial.

Amadi B, Mwiya M, Musuku J, Watuka A, Sianongo S, Ayoub A, Kelly P.

Lancet. 2002 Nov 2;360(9343):1375-80.

PMID:
12423984
7.

Cryptosporidiosis and the challenges of chemotherapy.

Mead JR.

Drug Resist Updat. 2002 Feb;5(1):47-57. Review.

PMID:
12127863
8.
9.

Treatment of intestinal parasitic infections: a review of nitazoxanide.

Gilles HM, Hoffman PS.

Trends Parasitol. 2002 Mar;18(3):95-7. No abstract available.

PMID:
11854075
10.

Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients.

Hunter PR, Nichols G.

Clin Microbiol Rev. 2002 Jan;15(1):145-54. Review.

11.

A randomized, blinded, controlled trial investigating the gastrointestinal health effects of drinking water quality.

Hellard ME, Sinclair MI, Forbes AB, Fairley CK.

Environ Health Perspect. 2001 Aug;109(8):773-8.

12.

Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide.

Rossignol JF, Ayoub A, Ayers MS.

J Infect Dis. 2001 Jul 1;184(1):103-6. Epub 2001 May 29.

PMID:
11398117
13.
14.

Cryptosporidiosis in Benha, study of some recent modalities in diagnosis and treatment.

Abdel-Maboud AI, Rossignol JF, el-Kady MS, Mostafa MS, Kabil SM.

J Egypt Soc Parasitol. 2000 Dec;30(3):717-25.

PMID:
11198369
15.

Rifabutin but not clarithromycin prevents cryptosporidiosis in persons with advanced HIV infection.

Fichtenbaum CJ, Zackin R, Feinberg J, Benson C, Griffiths JK; AIDS Clinical Trials Group New Works Concept Sheet Team 064.

AIDS. 2000 Dec 22;14(18):2889-93.

PMID:
11153670
16.

Eradication of cryptosporidia and microsporidia following successful antiretroviral therapy.

Miao YM, Awad-El-Kariem FM, Franzen C, Ellis DS, Müller A, Counihan HM, Hayes PJ, Gazzard BG.

J Acquir Immune Defic Syndr. 2000 Oct 1;25(2):124-9.

PMID:
11103042
18.

Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial Group.

Hewitt RG, Yiannoutsos CT, Higgs ES, Carey JT, Geiseler PJ, Soave R, Rosenberg R, Vazquez GJ, Wheat LJ, Fass RJ, Antoninievic Z, Walawander AL, Flanigan TP, Bender JF.

Clin Infect Dis. 2000 Oct;31(4):1084-92. Epub 2000 Oct 25.

PMID:
11049793
19.

Effect of antiretroviral therapy on cryptosporidiosis and microsporidiosis in patients infected with human immunodeficiency virus type 1.

Maggi P, Larocca AM, Quarto M, Serio G, Brandonisio O, Angarano G, Pastore G.

Eur J Clin Microbiol Infect Dis. 2000 Mar;19(3):213-7.

PMID:
10795595

Supplemental Content

Support Center